EP Patent

EP0314764A1 — INJECTABLE OPACIFYING LIPOSOMIC COMPOSITION.

Assigned to Dibra SpA · Expires 1989-05-10 · 37y expired

What this patent protects

Injectable aqueous composition intended for opacifying certain organs with a view to X-ray examination. This composition is based on liposomes in which an aqueous solution of an iodinated opacifying agent is encapsulated. The ratio between the weight of iodine encapsulated by the…

USPTO Abstract

Injectable aqueous composition intended for opacifying certain organs with a view to X-ray examination. This composition is based on liposomes in which an aqueous solution of an iodinated opacifying agent is encapsulated. The ratio between the weight of iodine encapsulated by the liposomes and the weight of the lipids constituting their membrane is not less than 1.5 mg / mg.

Drugs covered by this patent

Patent Metadata

Patent number
EP0314764A1
Jurisdiction
EP
Classification
Expires
1989-05-10
Drug substance claim
No
Drug product claim
No
Assignee
Dibra SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.